RLM Consulting

RLM Consulting provides a wide range of regulatory affairs supports for the development of disruptive IMP/IND, from early nonclinical development to the late phases of clinical development. We aim to accelerate your journey with the best regulatory pathway in the EU and USA. Our consultants, all highly skilled in science and regulatory affairs can guide you on the CMC, nonclinical and clinical requirements. We act as an applicant for various submissions, and we write your dossier.